# A Safety and Efficacy Study of Doripenem in Participants With Nosocomial Pneumonia, Complicated Intra-Abdominal Infections and Urinary Tract Infections

> **NCT00965848** · PHASE4 · COMPLETED · sponsor: **Janssen-Cilag Ltd.,Thailand** · enrollment: 270 (actual)

## Conditions studied

- Infection
- Cross Infection
- Bacterial Infections
- Pneumonia, Ventilator-Associated
- Intra-abdominal Infections
- Urinary Tract Infections

## Interventions

- **DRUG:** Doripenem

## Key facts

- **NCT ID:** NCT00965848
- **Lead sponsor:** Janssen-Cilag Ltd.,Thailand
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2010-07
- **Final completion:** 2010-07
- **Target enrollment:** 270 (ACTUAL)
- **Last updated:** 2013-10-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00965848

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00965848, "A Safety and Efficacy Study of Doripenem in Participants With Nosocomial Pneumonia, Complicated Intra-Abdominal Infections and Urinary Tract Infections". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00965848. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*